Nurix Therapeutics Inc
NRIX11.280USD
+0.240+2.17%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
11.280USD+11.280After-hours (ET)
862.17MMarket Cap
LossP/E TTM
Nurix Therapeutics Inc
11.280
+0.240+2.17%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
Total revenue
11.26%18.45M
-12.37%13.28M
-31.84%12.59M
-60.58%12.09M
30.74%16.59M
123.49%15.16M
71.13%18.47M
168.33%30.68M
31.85%12.69M
-8.29%6.78M
5.26%10.79M
61.22%11.43M
92.00%9.62M
10.57%7.40M
150.97%10.25M
69.56%7.09M
74.97%5.01M
259.24%6.69M
-61.39%4.08M
-55.69%4.18M
-68.98%2.86M
--1.86M
--10.58M
--9.44M
--9.23M
Revenue
11.26%18.45M
-12.37%13.28M
-31.84%12.59M
-60.58%12.09M
30.74%16.59M
123.49%15.16M
71.13%18.47M
168.33%30.68M
31.85%12.69M
-8.29%6.78M
5.26%10.79M
61.22%11.43M
92.00%9.62M
10.57%7.40M
150.97%10.25M
69.56%7.09M
74.97%5.01M
259.24%6.69M
-61.39%4.08M
-55.69%4.18M
-68.98%2.86M
--1.86M
--10.58M
--9.44M
--9.23M
Operating expenses
31.57%81.32M
28.84%77.94M
14.91%67.20M
5.56%60.63M
11.08%61.80M
9.05%60.49M
1.69%58.48M
0.51%57.44M
6.25%55.64M
22.32%55.47M
46.52%57.51M
70.56%57.15M
77.31%52.37M
69.87%45.35M
68.62%39.25M
92.42%33.51M
91.56%29.53M
73.06%26.70M
76.45%23.28M
37.87%17.41M
27.37%15.42M
--15.43M
--13.19M
--12.63M
--12.10M
R&D expenses
39.31%69.66M
35.22%67.22M
15.93%55.48M
6.90%48.92M
9.14%50.01M
7.82%49.71M
0.20%47.86M
-3.64%45.76M
6.21%45.82M
26.21%46.11M
54.54%47.76M
82.71%47.49M
87.53%43.14M
78.68%36.53M
63.19%30.91M
83.81%25.99M
77.40%23.00M
59.43%20.45M
72.05%18.94M
31.44%14.14M
24.28%12.97M
--12.82M
--11.01M
--10.76M
--10.43M
Depreciation, depletion, and amortization
6.17%4.13M
14.53%4.30M
22.52%4.15M
22.74%4.09M
22.26%3.89M
23.71%3.76M
17.26%3.38M
26.63%3.33M
41.15%3.18M
-24.99%3.04M
287.38%2.89M
308.06%2.63M
250.39%2.25M
528.73%4.05M
35.45%745.00K
30.30%645.00K
30.96%643.00K
17.30%644.00K
-1.08%550.00K
-17.91%495.00K
-23.99%491.00K
--549.00K
--556.00K
--603.00K
--646.00K
Operating profit
-39.02%-62.86M
-42.62%-64.66M
-36.49%-54.61M
-81.36%-48.54M
-5.28%-45.22M
6.89%-45.33M
14.35%-40.01M
41.45%-26.77M
-0.49%-42.95M
-28.29%-48.69M
-61.11%-46.72M
-73.07%-45.72M
-74.31%-42.74M
-89.69%-37.95M
-51.09%-29.00M
-99.65%-26.41M
-95.35%-24.52M
-47.51%-20.01M
-634.76%-19.19M
-314.73%-13.23M
-337.39%-12.55M
---13.56M
---2.61M
---3.19M
---2.87M
Net non-operating interest income (expenses)
Non-operating interest income
71.80%6.51M
81.05%6.12M
89.34%5.74M
64.15%4.08M
70.84%3.79M
71.21%3.38M
200.30%3.03M
692.36%2.49M
951.66%2.22M
568.81%1.97M
2487.18%1.01M
83.63%314.00K
-33.65%211.00K
118.52%295.00K
-94.22%39.00K
-23.32%171.00K
83.82%318.00K
-47.06%135.00K
246.15%675.00K
68.94%223.00K
-10.82%173.00K
--255.00K
--195.00K
--132.00K
--194.00K
Income before tax
-36.02%-56.35M
-39.53%-58.54M
-32.16%-48.87M
-83.12%-44.46M
-1.71%-41.43M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-24.06%-46.72M
-57.85%-45.71M
-73.00%-45.40M
-75.73%-42.53M
-89.49%-37.66M
-56.39%-28.96M
-101.76%-26.24M
-95.51%-24.20M
-49.32%-19.87M
-666.12%-18.52M
-325.34%-13.01M
-362.63%-12.38M
---13.31M
---2.42M
---3.06M
---2.68M
Income tax
-100.00%0.00
--8.00K
--82.00K
--90.00K
--90.00K
----
----
----
----
-100.00%0.00
100.00%0.00
-100.00%0.00
-100.00%0.00
7.32%44.00K
---123.00K
100.68%139.00K
545.45%71.00K
-80.48%41.00K
-100.00%0.00
-205970.00%-20.59M
22.22%11.00K
--210.00K
--10.00K
--10.00K
--9.00K
Income after tax
-35.73%-56.35M
-39.55%-58.55M
-32.38%-48.96M
-83.49%-44.55M
-1.93%-41.52M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-23.91%-46.72M
-58.52%-45.71M
-72.09%-45.40M
-75.21%-42.53M
-89.32%-37.70M
-55.72%-28.84M
-448.05%-26.38M
-95.91%-24.27M
-47.30%-19.91M
-662.96%-18.52M
347.07%7.58M
-361.49%-12.39M
---13.52M
---2.43M
---3.07M
---2.69M
Net income from continuous operations
-35.73%-56.35M
-39.55%-58.55M
-32.38%-48.96M
-83.49%-44.55M
-1.93%-41.52M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-23.91%-46.72M
-58.52%-45.71M
-72.09%-45.40M
-75.21%-42.53M
-89.32%-37.70M
-55.72%-28.84M
-448.05%-26.38M
-95.91%-24.27M
-47.30%-19.91M
-662.96%-18.52M
347.07%7.58M
-361.49%-12.39M
---13.52M
---2.43M
---3.07M
---2.69M
Net income attributable to controlling interests
-35.73%-56.35M
-39.55%-58.55M
-32.38%-48.96M
-83.49%-44.55M
-1.93%-41.52M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-23.91%-46.72M
-58.52%-45.71M
-72.09%-45.40M
-75.21%-42.53M
-89.32%-37.70M
-55.72%-28.84M
-448.05%-26.38M
-95.91%-24.27M
-47.30%-19.91M
-662.96%-18.52M
347.07%7.58M
-361.49%-12.39M
---13.52M
---2.43M
---3.07M
---2.69M
Net income attributable to common shareholders
-35.73%-56.35M
-39.55%-58.55M
-32.38%-48.96M
-83.49%-44.55M
-1.93%-41.52M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-23.91%-46.72M
-58.52%-45.71M
-72.09%-45.40M
-75.21%-42.53M
-89.32%-37.70M
-55.72%-28.84M
-448.05%-26.38M
-95.91%-24.27M
-47.30%-19.91M
-662.96%-18.52M
347.07%7.58M
-361.49%-12.39M
---13.52M
---2.43M
---3.07M
---2.69M
Basic earnings per share
10.82%-0.67
2.60%-0.75
1.07%-0.67
-59.61%-0.71
-0.30%-0.76
11.41%-0.77
24.33%-0.68
55.75%-0.45
20.78%-0.75
-2.37%-0.87
-38.28%-0.90
-67.90%-1.01
-52.02%-0.95
-65.17%-0.85
-10.13%-0.65
-190.41%-0.60
42.52%-0.63
56.87%-0.51
-176.62%-0.59
347.06%0.67
-361.50%-1.09
---1.19
---0.21
---0.27
---0.24
Diluted earnings per share
10.82%-0.67
2.60%-0.75
1.07%-0.67
-59.61%-0.71
-0.30%-0.76
11.41%-0.77
24.33%-0.68
55.75%-0.45
20.78%-0.75
-2.37%-0.87
-38.28%-0.90
-67.90%-1.01
-52.02%-0.95
-65.17%-0.85
-10.13%-0.65
-190.41%-0.60
42.52%-0.63
56.87%-0.51
-176.62%-0.59
347.06%0.67
-361.50%-1.09
---1.19
---0.21
---0.27
---0.24
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
